Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving oxidoreductase
Reexamination Certificate
2005-02-15
2005-02-15
Saucier, Sandra E. (Department: 1651)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving oxidoreductase
Reexamination Certificate
active
06855511
ABSTRACT:
Methods whereby, by reference to fructosamine oxidase activity in blood plasma of a patient or patients, the risk of diabetes associated vascular complications can be assessed, candidate fructosamine oxidase inhibitors and/or antagonists can be identified or tested and the inhibition and/or antagonism of the fructosamine oxidase inhibition and/or antagonism of a patient can be assessed.
REFERENCES:
patent: 4374829 (1983-02-01), Harris et al.
patent: 4410541 (1983-10-01), Kamimae et al.
patent: 4758583 (1988-07-01), Cerami et al.
patent: 4866090 (1989-09-01), Hoffman et al.
patent: 4952568 (1990-08-01), Sawai et al.
patent: 5128360 (1992-07-01), Cerami et al.
patent: 5246970 (1993-09-01), Williamson et al.
patent: 5852009 (1998-12-01), Cerami et al.
patent: 3091889 (1989-09-01), None
patent: 8093694 (1995-05-01), None
patent: 1447095 (1995-07-01), None
patent: 4134996 (1996-05-01), None
patent: 3 217 071 (1983-11-01), None
patent: 0 426 066 (1991-05-01), None
patent: 2 192 789 (1988-01-01), None
patent: 2 192 790 (1988-01-01), None
patent: 57-144215 (1982-09-01), None
patent: WO 8705505 (1987-09-01), None
patent: WO 9939712 (1999-08-01), None
patent: WO 0018392 (2000-04-01), None
patent: WO 0018891 (2000-04-01), None
Chemistry Abstracts Registry numbers 4429-04-3, 57-48-7, 1 854-25-7.*
American Diabetes Association. (1997). “Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus,”Diabetes Care20:1183-1197.
American Diabetes Association. (1998). “Economic Consequences of Diabetes Mellitus in the U.S. in 1997,”Diabetes Care21(2):296-309.
Barthelmebs, M. et al. (1990). “L-Dopa and Streptozotocin-Induced Diabetic Nephropathy in Rats,”American Journal of Hypertension3(6 Part 2):72S-74S.
Barthelmebs, M. et al. (1991). “Effects of Dopamine Prodrugs and Fenoldopam on Glomerular Hyperfiltration in Streptozotocin-Induced Diabetes in Rats”Journal of Cardiovascular Pharmacology18(2):243 -253.
Barthelmebs, M. et al. (1995); “Pathophysiological Role of Dopamine in the Kidney: Effects in Diabetes Mellitus and after Contralateral Nephrectomey,”Hypertens. Res.18(Suppl. I):S131-S136.
Baynes, J.W. (1991). “Role of Oxidative Stress in Development of Complications in Diabetes,”Diabetes40:405-412.
Boiadzhieva,N. (1990). “The Effect of Doparninergic Pharmocological Agents on the Pancreatic Islet Apparatus in Rats,”Eksp. Med. Morfol.29(3):20-26. (English abstract).
Borgstrom, L. et al. (1986). “Pharmacokinetics of N-Acetylcysteine in Man,”Eur. J. Clin. Pharmacol.31:217-222.
Chan, P.C. and Bielski, B.H.J. (1974). “Enzyme-catalyzed Free Radical Reactions with Nicotinamide Adenine Nucleotides,”J. Biol. Chem.249(4):1317-1319.
Chan, P.C. and Bieiski, B.H.J. (1980). “Glyceraldehyde-3-Phosphate Dehydrogenase-catalyzed Chain Oxidation of Reduced Nicotinamide Adenine Dinucleotide by Perhydroxyl Radicals,”J. Biol Chem.255(3):874-876.
Chaturvedi, N. et al. (1998). “Effect of Lisinopril on Progression of Retinopathy in Norniotensive People with Type 1 Diabetes,”The Lance351:28-31.
Deckert T. et al. (1978). “Prognosis of Diabetics with Diabetes Onset before the Age of Thirtyone,”Diabetologia14:363-370.
Dubois, R.S. et al. (1970). “Triethylene Tetramine Dihydrochloride in Wilson's Disease,”Lancet2(7676):775.
Duchin, K.L. et al. (1988). “Pharmacokinetics of Captopril in Healthy Subjects and in Patients with Cardiovascular Diseases,”Clin. Pharmacokinetics14:241-259.
Elstner, E.F. and Heupel, A. (1976). “Inhibition of Nitrite Formation from Hydroxylammonium-chloride: A Simple Assay for Superoxide Dismutase,”Anal. Biochem.70:616-620.
Epstein, O. and Sherlock, S. (1980). “Triethylene Tetramine Dihydrochloride Toxicity in Primary Biliary Cirrhosis,”Gastroenterology78(6):1442-1445.
Executive Committee of the International Union of Biochemistry, ed. (1979).Enzyme Nomenclature, Recommendations of the Nomenclature Committee of the International Union of Biochemistry, Academic Press: London, pp. 19-22. (Table of Contents).
Gennaro, A.R. ed. (1990).Remington's Pharmaceutical Sciences.18th edition. Mack Publishing Company: Easton, Pennsylvania, 5 pages.(Table of Contents).
Gerhardinger, C. et al. (1995). “Novel Degradation Pathway of Glycated Amino Acids into Free Frudtosamine by a Pseudomonas sp. Soil Strain Extract,”J. Biol. Chem.270(1):218-224.
Greenstock, C.L. and Ruddock, G.W. (1976). “Determination of Superoxide (O2) Radical Anion Reaction Rates Using Pulse Radiolysis,”Int. J. Radiat. Phys. Chem.8:367-369.
Halliwell, B. (1976). “An Attempt to Demonstrate a Reaction between Superoxide and Hydrogen Peroxide,”FEBS Left.72( 1):8-10.
Halliwell, B. and Gutteridge, J.M.C. (1989). “The Superoxide Theory of Oxygen Toxicity,” inFree Radicals in Biology and Medicine.Clarendon Press: Oxford, pp. 136-176.
Haslam, R.H. et al. (1980). “Treatment of Wilson's Disease with TriethyleneTetramine Dihydrochloride,”Dev. Pharmacol. Ther.1(5):318-324.
Holdiness M.R. (1991). “Clinical Pharmacokinetics of N-Acetylcysteine,”Clin. Pharmacokinet.20(2):123-134.
Horiuchi, T. et al. (1989). “Purification and.Properties of Fructosyl-amino Acid Oxidase from Corynebacterium sp. 2-4-1,”Agric. Biol. Chem.53(1):103-110.
Ido, Y. et al. (1996). “Interactions between the Sorbitol Pathway, Non-enzymatic Glycation, and Diabetic Vascular Dysfunction,”Nephrol. Dial. Transplant.11(Suppl 5):72-75.
Karisson, K. and Markiund, S.L. (1987). “Heparin-induced Release of Extracellular Superoxide Dismutase to Human Blood Plasma,”Biochem. J.242:55-59.
Kashihara, N. et al. (1992). “Selective Decreased de novo Synthesis of Glomerular Proteoglycans under the Influence of Reactive Oxygen Species,”Proc. NatI. Acad. Sci. USA89:6309-6313.
Klein, R.et al. (1985). “Retinopathy in Young-Onset Diabetic Patients,”Diabetes Care8(4):311-315.
Kodama, H. et al. (1997). “Metabolism of Administered Triethylene Tetramine Dihydrochioride in Humans,”Life Sci.61(9):899-907.
Marklund, S.L. et al. (1982). “Superoxide Dismnutase in Extracellular Fluids,”Clin. Chimica Acta126:41-51.
Mattock, M.B. Ct al. (1998). “Microalbuminuria and Coronary Heart Disease in NIDDM: An Incidence Study,”Diabetes47:1786-1792.
McCord, J.M. and Fridovich, I. (1969). “Superoxide Dismutase: An Enzymic Function for Erythrocuprein (Hemocuprein),”J. Biol. Chem.244(22):6049-6055.
Misra, H.P. and Fridovich, I. (1972). “The Role of Superoxide Anion in the Autoxidation of Epinephrine and a Simple Assay for Superoxide Dismutae,”J. Biol. Chem.247(10):3170-3175.
Misra, H.P. and Fridovich, I. (1977). “Superoxide Dismutase: ‘Positive’ Spectrophotometric Assays,”Anal. Biochem.79:553-560.
Mizobuchi, N. et at. (1993). “Serum Superoxide Dismutase (SOD) Activity in Diabetes Mellitus,”Rinsho Byori41:673-678. (English abstract).
Mogensen, C.E. and Christensen, C.K. (1984). “Predicting Diabetic Nephropathy in Insulin-dependent Patients,”New. Eng. J. Med311(2):89-93.
Mogensen, C.E. et al. (1992). “Microalbuminuria in Non-Insulin-Dependent Diabetes,”Clin. Nephrol.38(suppl 1):S28-S38.
Morpurgo, L. et at. (1990). “The Role of Copper in Bovine Serum Amine Oxidase,”Biol Metals3:114-117.
Obach, R. et al. (1984). “The Pharmacokinetic Profile of Carbidopa in Dogs,”J. Pharm. Pharmacol.36:415-416.
Palcic, M.M. and Janes, S.M. (1995). “Spectrophotometric.Detection of Topa Quinone,”Meth. Enzymol.258:34-38.
Pappert, E.J. et al. (1997). “The Stability of Carbidopa in Solution,”Movement Disorders12(4):608-623.
Picard, S. et al. (1996). “Minimally Oxidised LDL as Estimated by a New Method Increase in Plasma of Type 2 Diabetic Patients with Atherosclerosis of N
Buchanan Ingersoll P.C.
Protemix Corporation Limited
Saucier Sandra E.
LandOfFree
Fructosamine oxidase assay: methods and materials does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fructosamine oxidase assay: methods and materials, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fructosamine oxidase assay: methods and materials will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3467094